Rhythm Pharmaceuticals, Inc.
500 Boylston Street, 11th Floor
Boston, MA 02116
October 2, 2017
VIA EDGAR AND E-MAIL
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-6010
|
Attention: |
|
Suzanne Hayes |
|
|
|
Mary Beth Breslin |
|
|
|
Christine Westbrook |
|
|
|
James Peklenk |
|
|
|
James Rosenberg |
|
|
|
|
|
Re: |
|
Rhythm Pharmaceuticals, Inc. Registration Statement on Form S-1 (Registration No. 333-220337) |
Ladies and Gentlemen:
In accordance with Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the Registration Statement on Form S-1 (File No. 333-220337) (the “Registration Statement”) of Rhythm Pharmaceuticals, Inc. (the “Company”). We respectfully request that the Registration Statement become effective as of 4:00 p.m., Eastern time, on October 4, 2017, or as soon as practicable thereafter. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Morgan, Lewis & Bockius LLP, by calling Laurie Cerveny at (617) 951-8527.
[Remainder of page intentionally left blank]
|
|
Very truly yours, | ||
|
|
| ||
|
|
Rhythm Pharmaceuticals, Inc. | ||
|
|
| ||
|
|
By: |
/s/Keith M. Gottesdiener | |
|
|
|
Keith M. Gottesdiener, | |
|
|
|
Chief Executive Officer and President | |
|
|
| ||
|
CC: |
Hunter Smith, Rhythm Pharmaceuticals, Inc. | ||
|
|
Julio Vega, Morgan, Lewis & Bockius LLP | ||
|
|
Laurie A Cerveny, Morgan, Lewis & Bockius LLP | ||
|
|
Lisa Firenze, Wilmer Cutler Pickering Hale and Dorr LLP | ||
|
|
Craig Hilts, Wilmer Cutler Pickering Hale and Dorr LLP | ||
[Rhythm Pharmaceuticals, Inc. – Signature Page to Request for Acceleration]